Akari Therapeutics PLC (AKTX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -45.305 | -69.942 | -73.633 | -146.921 | -162.03 | -132.739 | -122.091 | -112.345 |
| Return on Equity (%) | -49.404 | -80.468 | -90.031 | -251.733 | -363.756 | -233.269 | -315.194 | -393.127 |
| Return on Invested Capital (%) | -51.315 | -80.292 | -103.518 | -250.807 | -371.529 | -230.819 | -409.509 | -577.602 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.035 | 0.02 | 0.008 | N/A | 0.004 | 0.001 | 0.001 | N/A |
| Earnings Per Share | -0.022 | -0.019 | -0.013 | -0.011 | -0.008 | -0.004 | -0.002 | -0.001 |
| Cash Per Share | 0.029 | 0.019 | 0.004 | 0.004 | 0.006 | 0.002 | 0.002 | N/A |
| Working Capital Per Share | 0.035 | 0.02 | 0.008 | N/A | 0.004 | 0.001 | 0.001 | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.022 | -0.025 | -0.015 | -0.011 | -0.008 | -0.004 | -0.003 | -0.001 |
| EBITDA Per Share | -0.022 | -0.025 | -0.015 | -0.011 | -0.008 | -0.004 | -0.003 | -0.001 |
| Free Cash Flow Per Share | -0.022 | -0.019 | -0.013 | -0.011 | -0.008 | -0.004 | -0.002 | -0.001 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 1.18B | 1.53B | 1.58B | 1.58B | 2.25B | 4.76B | 7.44B | 13.23B |
| Year End December 30 2023 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | N/A | 2.25B | N/A | N/A | N/A | 4.76B | N/A | 5.93B |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 24.02M |
| Price to Earnings Ratio | -1.96 |
| Price to Sales Ratio | 72.93 |
| Price to Cash Ratio | 6.25 |
| Price to Book Ratio | 24.31 |
| Dividend Yield | - |
| Shares Outstanding | 24.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
